Literature DB >> 2386553

Binding of retelliptine, a new antitumoral agent, to serum proteins and erythrocytes.

C Maulard1, S Urien, G Bastian, J P Tillement.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2386553     DOI： 10.1016/0006-2952(90)90333-g

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  3 in total

1.  Binding of a new vinca alkaloid derivative, S12363, to human plasma proteins and platelets. Usefulness of an erythrocyte partitioning technique.

Authors:  S Urien; G Bastian; C Lucas; J P Bizzari; J P Tillement
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

2.  Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytes.

Authors:  S Urien; P Nguyen; G Bastian; C Lucas; J P Tillement
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

3.  The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum.

Authors:  B Cenni; J Meyer; R Brandt; B Betschart
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.